SEC Updates Guidance on Expiring Confidential Treatment Orders

Dorsey & Whitney LLP

Dorsey & Whitney LLPOn September 9, the SEC’s Division of Corporation Finance updated its guidance to outline three alternatives for handling an expiring confidential treatment order (“CTO”):

1) If the contract continues to be material but the previously redacted information is no longer confidential: refile the unredacted exhibit.

2) If the contract continues to be material, and the previously redacted information continues to be confidential, request to extend the confidential period under Securities Act Rule 406 or Exchange Act Rule 24b-2 by:

a) submitting the short form application if the CTO was issued less than three years ago; or

b) filing a new, complete application for confidential treatment under Rule 406 or Rule 24b-2 if the CTO was issued more than three years ago.

3) Transition to the “streamlined” process for redacting exhibits set out in Item 601(b)(10) of Regulation S-K and other parallel rules, if the CTO was issued more than three years ago and the contract continues to be material.

The SEC’s staff expects many, if not most, companies will choose to transition to the streamlined process in the third option, under which substantiation of compliance and submission of unredacted materials to the staff is only required upon staff request.

DISCLAIMER: Because of the generality of this update, the information provided herein may not be applicable in all situations and should not be acted upon without specific legal advice based on particular situations.

© Dorsey & Whitney LLP | Attorney Advertising

Written by:

Dorsey & Whitney LLP

Dorsey & Whitney LLP on:

Reporters on Deadline

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
Custom Email Digest
- hide
- hide

This website uses cookies to improve user experience, track anonymous site usage, store authorization tokens and permit sharing on social media networks. By continuing to browse this website you accept the use of cookies. Click here to read more about how we use cookies.